Stoke Therapeutics, Inc.

Bank of New York Mellon Corp STOK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

140,802

Value ($000)

4,469

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	4,469	0.0%	140,802	12/31/2025
2025 Q3	11/3/2025	2,830	0.0%	120,436	9/30/2025
2025 Q2	8/5/2025	1,178	0.0%	103,773	6/30/2025
2025 Q1	4/29/2025	598	0.0%	89,985	3/31/2025
2024 Q4	2/4/2025	1,028	0.0%	93,195	12/31/2024
2024 Q3	11/12/2024	1,129	0.0%	91,865	9/30/2024
2024 Q2	7/25/2024	1,566	0.0%	115,892	6/30/2024
2024 Q1	4/25/2024	1,214	0.0%	89,904	3/31/2024
2023 Q4	1/29/2024	517	0.0%	98,328	12/31/2023
2023 Q3	10/24/2023	423	0.0%	107,254	9/30/2023
2023 Q2	8/3/2023	1,109	0.0%	104,328	6/30/2023
2023 Q1	5/9/2023	746	0.0%	89,582	3/31/2023
2022 Q4	2/14/2023	838	0.0%	90,775	12/31/2022
2022 Q3	11/14/2022	1,029	0.0%	80,180	9/30/2022
2022 Q2	8/15/2022	947	0.0%	71,624	6/30/2022
2022 Q1	5/11/2022	1,320	0.0%	62,698	3/31/2022
2021 Q4	2/11/2022	1,484	0.0%	61,861	12/31/2021
2021 Q3	11/18/2021	1,525	0.0%	59,937	9/30/2021
2021 Q2	8/11/2021	1,830	0.0%	54,372	6/30/2021
2021 Q1	5/13/2021	1,988	0.0%	51,180	3/31/2021
2020 Q4	2/9/2021	3,358	0.0%	54,235	12/31/2020
2020 Q3	11/12/2020	1,639	0.0%	48,954	9/30/2020
2020 Q2	8/12/2020	1,216	0.0%	51,044	6/30/2020
2020 Q1	5/6/2020	1,311	0.0%	57,262	3/31/2020
2019 Q4	2/14/2020	954	0.0%	33,681	12/31/2019